Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | |
|---|---|---|---|---|---|---|
| Total revenue | -9.81%207.13M | 79.72%229.66M | 141.28%127.78M | 23.13%52.96M | 43.01M | |
| Operating revenue | ---- | -9.81%207.13M | 79.72%229.66M | 141.28%127.78M | 23.13%52.96M | --43.01M |
| Cost of revenue | ||||||
| Gross profit | -9.81%207.13M | 79.72%229.66M | 141.28%127.78M | 23.13%52.96M | 43.01M | |
| Operating expense | 50.61%155.56M | -24.49%103.29M | -10.22%136.79M | 167.25%152.36M | 62.71%57.01M | 35.04M |
| Selling and administrative expenses | 11.52%48.43M | 0.08%43.43M | -13.54%43.39M | 118.93%50.19M | 49.15%22.93M | --15.37M |
| -Selling and marketing expense | 15.89%8.12M | -11.40%7.01M | -64.11%7.91M | 131.20%22.03M | 88.71%9.53M | --5.05M |
| -General and administrative expense | 10.68%40.32M | 2.64%36.42M | 26.01%35.49M | 110.20%28.16M | 29.80%13.4M | --10.32M |
| Depreciation amortization depletion | -12.32%9.6M | -3.47%10.95M | 406.48%11.34M | 32.56%2.24M | 71.47%1.69M | --985K |
| -Depreciation and amortization | -12.32%9.6M | -3.47%10.95M | 406.48%11.34M | 32.56%2.24M | 71.47%1.69M | --985K |
| Provision for doubtful accounts | 108.65%71.74M | -49.09%34.39M | -25.79%67.54M | 216.57%91.02M | 80.00%28.75M | --15.97M |
| Other operating expenses | 77.49%25.78M | 0.12%14.53M | 62.77%14.51M | 144.55%8.91M | 34.50%3.65M | --2.71M |
| Operating profit | -249.80%-155.56M | 11.81%103.84M | 477.87%92.87M | -506.86%-24.58M | -150.80%-4.05M | 7.97M |
| Net non-operating interest income (expenses) | 198.00%96.51M | -9.65%-98.47M | -133.30%-89.81M | -263.31%-38.49M | 16.91%-10.6M | -12.75M |
| Non-operating interest income | --201.23M | ---- | ---- | ---- | ---- | ---- |
| Non-operating interest expense | 6.44%104.58M | 9.61%98.25M | 133.40%89.63M | 267.18%38.4M | -16.95%10.46M | --12.59M |
| Total other finance cost | -33.48%149K | 30.23%224K | 91.11%172K | -33.82%90K | -13.38%136K | --157K |
| Other net income (expenses) | -213.64%-7.98M | -23.87%7.02M | -39.71%9.22M | 231.43%15.29M | -1.01%4.61M | 4.66M |
| Other non-operating income (expenses) | -213.64%-7.98M | -23.87%7.02M | -39.71%9.22M | 231.43%15.29M | -1.01%4.61M | --4.66M |
| Income before tax | -637.73%-66.61M | 0.82%12.39M | 125.71%12.29M | -376.30%-47.78M | -8,330.25%-10.03M | -119K |
| Income tax | 0 | -10.34M | 0 | 222.78%2.58M | -48.31%-2.1M | -1.42M |
| Earnings from equity interest net of tax | ||||||
| Net income | -393.10%-66.61M | 84.97%22.73M | 124.39%12.29M | -535.19%-50.36M | -710.39%-7.93M | 1.3M |
| Net income continuous operations | -393.10%-66.61M | 84.97%22.73M | 124.39%12.29M | -535.19%-50.36M | -710.39%-7.93M | --1.3M |
| Noncontrolling interests | ||||||
| Net income attributable to the company | -393.10%-66.61M | 84.97%22.73M | 124.39%12.29M | -535.19%-50.36M | -710.39%-7.93M | 1.3M |
| Preferred stock dividends | ||||||
| Other under preferred stock dividend | ||||||
| Net income attributable to common stockholders | -393.10%-66.61M | 84.97%22.73M | 124.39%12.29M | -535.19%-50.36M | -710.39%-7.93M | 1.3M |
| Diluted earnings per share | -386.21%-0.083 | -23.68%0.029 | 114.39%0.038 | -461.70%-0.264 | -659.52%-0.047 | 0.0084 |
| Basic earnings per share | -386.21%-0.083 | -23.68%0.029 | 114.39%0.038 | -461.70%-0.264 | -659.52%-0.047 | 0.0084 |
| Dividend per share | ||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |